202 related articles for article (PubMed ID: 12386275)
1. Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm?
Ohtaka A; Ootaka T; Sato H; Ito S
Nephrol Dial Transplant; 2002; 17 Suppl 9():11-5. PubMed ID: 12386275
[TBL] [Abstract][Full Text] [Related]
2. Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis.
Ohtaka A; Ootaka T; Sato H; Soma J; Sato T; Saito T; Ito S
Am J Kidney Dis; 2002 Mar; 39(3):475-85. PubMed ID: 11877566
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
4. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies.
Hill GS; Karoui KE; Karras A; Mandet C; Van Huyen JD; Nochy D; Bruneval P
Kidney Int; 2011 Mar; 79(6):635-642. PubMed ID: 21160460
[TBL] [Abstract][Full Text] [Related]
5. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.
Sakamoto K; Ueno T; Kobayashi N; Hara S; Takashima Y; Pastan I; Matsusaka T; Nagata M
Am J Physiol Renal Physiol; 2014 Jan; 306(1):F98-F104. PubMed ID: 24154691
[TBL] [Abstract][Full Text] [Related]
6. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
[TBL] [Abstract][Full Text] [Related]
7. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
8. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ
Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009
[TBL] [Abstract][Full Text] [Related]
9. Parietal podocytes in normal human glomeruli.
Bariety J; Mandet C; Hill GS; Bruneval P
J Am Soc Nephrol; 2006 Oct; 17(10):2770-80. PubMed ID: 16943305
[TBL] [Abstract][Full Text] [Related]
10. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
12. Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis.
Kuppe C; Gröne HJ; Ostendorf T; van Kuppevelt TH; Boor P; Floege J; Smeets B; Moeller MJ
Kidney Int; 2015 Nov; 88(5):990-8. PubMed ID: 25853334
[TBL] [Abstract][Full Text] [Related]
13. Compound effects of aging and experimental FSGS on glomerular epithelial cells.
Schneider RR; Eng DG; Kutz JN; Sweetwyne MT; Pippin JW; Shankland SJ
Aging (Albany NY); 2017 Feb; 9(2):524-546. PubMed ID: 28222042
[TBL] [Abstract][Full Text] [Related]
14. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
15. Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources.
Kaverina NV; Eng DG; Schneider RR; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1397-413. PubMed ID: 27076646
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
17. Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease.
Zhang J; Pippin JW; Vaughan MR; Krofft RD; Taniguchi Y; Romagnani P; Nelson PJ; Liu ZH; Shankland SJ
Nephron Exp Nephrol; 2012; 121(1-2):e23-37. PubMed ID: 23107969
[TBL] [Abstract][Full Text] [Related]
18. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
19. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation.
Bariéty J; Bruneval P; Hill G; Irinopoulou T; Mandet C; Meyrier A
J Am Soc Nephrol; 2001 Feb; 12(2):261-274. PubMed ID: 11158216
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell foot process effacement in podocytes in focal and segmental glomerulosclerosis: a quantitative analysis.
Kfoury H
Ultrastruct Pathol; 2014 Oct; 38(5):303-8. PubMed ID: 24956069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]